Gadolinium & Nephrogenic Systemic Fibrosis (NSF) - News Articles

Lantheus Medical Imaging, Inc. Launches ABLAVAR® in Canada


disease (AIOD) in adults with known or suspected peripheral vascular disease. History of a prior allergic reaction to a gadolinium-based contrast agent. ...
Genzyme's Alemtuzumab Shows Sustained Reduction in Relapses and Disability in Five-Year Review of MS Patients from Phase 2 Trial - MarketWatch


Patients with highly active disease had at least two relapses in the year prior to treatment in the trial, and had at least one gadolinium enhancing brain lesion identified through magnetic resonance imaging (MRI). "In this Phase 2 trial, alemtuzumab was significantly more effective than Rebif ...
Nano-refridgerators


A new family of cobalt-gadolinium cage compounds are highly efficient for low temperature cooling, say European scientists. Liquid helium is currently used to achieve very low temperatures in a large amount of technology, such as super-conducting magnets that are needed for ...
Treating Relapsing-Remitting Multiple Sclerosis


In its Phase 2b monotherapy study, BG-12 reduced the mean number of new gadolinium enhancing (Gd+) lesions by 69% over weeks 12 through 24 in patients with RRMS compared to placebo. The presence of Gd+ lesions is thought to indicate inflammation within the nervous system. The ...
大纪元 - FDA警告:含钆显影剂 肾脏病患恐致命


FDA???????????????????,?????????????(nephrogenic systemic fibrosis, NSF),?????????????? ...
Rare earth elements undervalued

Proactive Investors Australia
Rare earth elements such as lanthanum, cerium, yttrium, gadolinium and their compounds may fetch low prices now, but they could have great application potential in the future. Hence, the central government should buy them to better defend strategic interests. And lastly, the ...
Cardiovascular magnetic resonance at 3.0T: Current state of the art


Specifically, we will review cine imaging, MR coronary angiography, myocardial perfusion imaging, late gadolinium enhancement, and vascular wall imaging. ...
Prediction of global left ventricular functional recovery in patients with heart failure undergoing surgical revascularisation, based on late gadolinium enhancement Cardiovascular Magnetic Resonance


The new gold standard for myocardial viability assessment is late gadolinium enhancement-cardiovascular magnetic resonance (LGE-CMR); this technique has demonstrated that the transmural extent of scar predicts segmental functional recovery. We now asked how the number of viable ...
Matamec Discovers 3 New TREO Showings in the Falaises Area - MarketWatch


Gd2O3 Gadolinium 0.019 0.046 0.053 ----------------------------------------------------------------- MREO(i) Medium rare earths 0.039 0.108 0.111 ----------------------------------------------------------------- Tb2O3 Terbium 0.003 0.004 0.007 ----------------------------------------------------------------- Dy2O3 Dysprosium 0.015 0.017 0.033 ----------------------------------------------------------------- Ho2O3 Holmium 0.003 0.003 0.006 ----------------------------------------------------------------- ...
China faces fierce competition from Japan over rare earth supplies - Land of the rising sun shows its metal | TechEye

The Japan Times
Gadolinium is used for making compact discs and computer memory while Neodymium is a component of computer hard drives. Professor Strange added: “I am sure ...
Bayer Launches Betaferon® In China


With its 1.0 mol/L concentration of gadobutrol, Gadovist 1.0 contains twice as much gadolinium per unit of volume as other extracellular contrast media available on the market. Gadovist 1.0 belongs to the class of macrocyclic gadolinium-binding contrast agents, which are characterized by ...
MRI Health Risks: FDA Increases Warnings


Nephrogenic systemic fibrosis can be misdiagnosed as either scleroderma or sclerodeema due to a lack of knowledge about NSF and gadolinium-based contrast agents. Furthermore, it can take a year and a half or more for NSF to develop, making it less ...


Dubbed ChemCam, the US/French device uses a Neodymium doped Potassium-Gadolinium Tungstate Nd:KGW laser to vaporize a spot on its target the size of a ...
Midland Exploration and JOGMEC Discovers Two New Rare Earth Bearing Mineralized Systems on the Ytterby Project, South of Strange Lake, Quebec - MarketWatch


0.19% dysprosium oxide (Dy2O3) and 0.35% gadolinium oxide (Gd2O3). A total of 292 assay results were received from 585 samples collected. On Ytterby 3, the better grade of mineralization is related to iron oxide enriched pegmatite-aplite dykes and plurimetric iron-oxide ...
TMD – Today’s Medical Developments : News


The technique works by first acquiring a 3-D coronary image using a continuous infusion of a contrast called gadolinium, which makes the blood-pool light up brightly. The 3-T MRI takes images as this contrast is infused into the blood stream, providing a high resolution, ...
News - Balancing the Risks of Natalizumab Dosing Holidays: Presented at ANA


It has been shown to decrease the relapse rate, reduce TC and gadolinium-enhancing (Gd+) lesions on magnetic resonance imaging (MRI), and slow the progression of disability. The problem is that longer treatment is associated with an increased risk for ...
¸ÞµðÄÃÇì·²µå


????????(NSF:nephrogenic systemic fibrosis)? ?? ?? ??? ??, ??, ?? ? ??? ????? ??? ??? ? ? ?? ????. ...


The risk of MRA is that of nephrogenic systemic fibrosis due to the gadolinium used in the MRA. Additional tests may be done depending on the clinical ...
´Å¹²ÕñɨÃèËùÓÃÈýÖÖÒ©Îï ¿ÉÄÜÒý·¢ÖÂÃü×´¿ö-ÉúÎïÒ½Ò©²úÒµ - ÉúÎï¹È


????,?????????????????????(gadolinium-based contrast agents),?????????(nephrogenic systemic fibrosis)?????? ...
US FDA briefs: fast-track for Zeltia’s Zentylor; OK for Baxter’s Protopam; warning on gadolinium-based contrast agents - Pharmaceutical and Biotechnology News - Pharma Letter


Noscira, a Spanish firm Grupo Zeltia (ZEL: MC) subsidiary specialized in R&D drugs to treat neurodegenerative diseases, has been granted US Food and Drug Administration fast track status for its neuroprotector drug Zentylor (tideglusib) to treat progressive supranuclear palsy (PSP), a fast-advancing fatal ...

Pages: Previous   1   2   3   4   5   6   7   8   9   10   11   ...   Next

Find a Gadolinium & Nephrogenic System Fibrosis (NSF) Lawyer Now

This form is secure and encrypted. More information about secure forms and your privacy here.
* Required Fields

PERSONAL INFORMATION

First Name: *
Last Name: *
Address:
City:
State:
Zipcode:
Phone: -- ext.
Work Phone: -- ext.
E-mail Address: *

CASE INFORMATION

Have you been diagnosed with NSF (Nephrogenic Systemic Fibrosis) or NFD (Nephrogenic Fibrosing Dermopathy)? Yes No
When and where was the diagnosis made?
When did your problems start?

Describe your symptoms and how they developed.
Did you have an MRI (Magnetic Resonance Imaging) or MRA (Magnetic Resonance Angiography) scan done before your symptoms began? Yes No
Where and when was the scan (or scans, if more than one) done?
Did you have kidney failure, kidney function deficiency, or other kidney problems at the time the scan (or scans) were done? Yes No
Describe the kidney problems you had.

Need A Gadolinium & Nephrogenic Systemic Fibrosis (NSF) Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please describe how you have been affected.

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Gadolinium & Nephrogenic Systemic Fibrosis (NSF) Case - Submit Your Information Below

Do you need legal assistance with your Gadolinium & Nephrogenic Systemic Fibrosis (NSF) case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Required Fields

PERSONAL INFORMATION

First Name: *
Last Name: *
Address:
City:
State:
Zipcode:
Phone: -- ext.
Work Phone: -- ext.
E-mail Address: *

CASE INFORMATION

Have you been diagnosed with NSF (Nephrogenic Systemic Fibrosis) or NFD (Nephrogenic Fibrosing Dermopathy)? Yes No
When and where was the diagnosis made?
When did your problems start?

Describe your symptoms and how they developed.
Did you have an MRI (Magnetic Resonance Imaging) or MRA (Magnetic Resonance Angiography) scan done before your symptoms began? Yes No
Where and when was the scan (or scans, if more than one) done?
Did you have kidney failure, kidney function deficiency, or other kidney problems at the time the scan (or scans) were done? Yes No
Describe the kidney problems you had.
This form is secure and encrypted. More information about secure forms and your privacy here.